Inhaler
Latest Novartis AG Patents:
- Compounds and compositions for the treatment of coronaviral related diseases
- TRISPECIFIC BINDING MOLECULES AGAINST TUMOR-ASSOCIATED ANTIGENS AND USES THEREOF
- Treatment for lupus nephritis using anti-BAFFR antibodies
- Anti-IgE antibody therapy for multiple food allergies
- Glue degraders and methods of use thereof
Description
Claims
The ornamental design of an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D614285
Type: Grant
Filed: Oct 29, 2007
Date of Patent: Apr 20, 2010
Assignee: Novartis AG (Basel)
Inventors: Martin Birath (Stockholm), Hans Himbert (Stockholm), Sofia Jacobsson (Bromma), Thomas Nilsson (Bromma), Ulrika Vejbrink (Hägersten)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Sandra S. Shim
Application Number: 29/292,809
Type: Grant
Filed: Oct 29, 2007
Date of Patent: Apr 20, 2010
Assignee: Novartis AG (Basel)
Inventors: Martin Birath (Stockholm), Hans Himbert (Stockholm), Sofia Jacobsson (Bromma), Thomas Nilsson (Bromma), Ulrika Vejbrink (Hägersten)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Sandra S. Shim
Application Number: 29/292,809
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)